PYRIDYL DERIVATIVES AS CFTR MODULATORS
The present invention relates to modulators of ATP-B inding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR"), compositions thereof, of formula (I), and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Europäisches Patentamt - (2018) vom: 07. Aug. Zur Gesamtaufnahme - year:2018 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
HADIDA-RUAH SARA [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2018-08-07, Last update posted on www.tib.eu: 2024-04-22, Last updated: 2024-04-26 |
|---|
| Patentnummer: |
CA2718310 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA003736814 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA003736814 | ||
| 003 | DE-627 | ||
| 005 | 20240426155248.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240426s2018 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA003736814 | ||
| 035 | |a (EPA)CA2718310 | ||
| 035 | |a (EPA)40790781 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a HADIDA-RUAH SARA |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a PYRIDYL DERIVATIVES AS CFTR MODULATORS |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2018-08-07, Last update posted on www.tib.eu: 2024-04-22, Last updated: 2024-04-26 | ||
| 520 | |a The present invention relates to modulators of ATP-B inding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR"), compositions thereof, of formula (I), and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators. | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a MILLER MARK |e verfasserin |4 aut | |
| 700 | 0 | |a ZHOU JINGLAN |e verfasserin |4 aut | |
| 700 | 0 | |a BEAR BRIAN |e verfasserin |4 aut | |
| 700 | 0 | |a GROOTENHUIS PETER |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2018) vom: 07. Aug. |
| 773 | 1 | 8 | |g year:2018 |g day:07 |g month:08 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/40790781/publication/CA2718310A1?q=CA2718310 |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2018 |b 07 |c 08 | ||